M
MBX Biosciences, Inc. (MBX)
NMS – Real vaqt narxi. Valyuta: USD
52.31
+1.94 (3.85%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
53.18
+0.87 (1.66%)
Bozordan keyin: Jun 26, 2026, 7:12 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
52.31
+1.94 (3.85%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
53.18
+0.87 (1.66%)
Bozordan keyin: Jun 26, 2026, 7:12 PM EDT
| Tarkibi | |
|---|---|
| 2.70% | Insayderlar egalik qilgan aksiyalar ulushi |
| 116.70% | Institusional investorlar egalik qilgan aksiyalar ulushi |
| 119.94% | Institusional investorlar egalik qilgan erkin aksiyalar ulushi |
| 212 | Institusional investorlar soni |
| Aksiyador | Aksiyalar | Hisobot sanasi | % ulushi | Qiymat |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6.65M | 2026-03-31 | 13.98% | $347.97M |
| Orbimed Advisors LLC. | 3.64M | 2026-03-31 | 7.64% | $190.30M |
| NEA Management Company, LLC | 3.61M | 2026-03-31 | 7.59% | $189.07M |
| Wellington Management Group, LLP | 3.19M | 2026-03-31 | 6.71% | $166.96M |
| Blackrock Inc. | 2.94M | 2026-03-31 | 6.18% | $153.86M |
| FMR, LLC | 2.94M | 2026-03-31 | 6.17% | $153.62M |
| Deep Track Capital, Lp | 2.76M | 2026-03-31 | 5.79% | $144.25M |
| NVP Associates, LLC | 2.14M | 2026-03-31 | 4.49% | $111.75M |
| Polar Capital Holdings PLC | 1.62M | 2026-03-31 | 3.41% | $84.86M |
| Braidwell LP | 1.49M | 2026-03-31 | 3.14% | $78.07M |
| Vanguard Capital Management LLC | 1.48M | 2026-03-31 | 3.10% | $47.95M |
| Aksiyador | Aksiyalar | Hisobot sanasi | % ulushi | Qiymat |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.16M | 2026-03-31 | 2.43% | $60.62M |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 890,000 | 2026-03-31 | 1.87% | $46.56M |
| T. Rowe Price Health Sciences Fund, Inc. | 721,309 | 2026-03-31 | 1.52% | $37.73M |
| iShares Trust-iShares Russell 2000 ETF | 670,413 | 2026-04-30 | 1.41% | $35.07M |
| Fidelity Select Portfolios-Select Health Care Portfolio | 600,000 | 2026-04-30 | 1.26% | $31.39M |
| Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund | 414,400 | 2026-02-28 | 0.87% | $21.68M |
| Franklin Strategic Series-FRANKLIN SMALL CAP GROWTH FUND | 348,601 | 2025-10-31 | 0.73% | $9.58M |
| BlackRock Funds-BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO | 340,569 | 2025-11-30 | 0.72% | $10.88M |
| BlackRock Funds-BlackRock Health Sciences Opportunities Portfolio | 333,350 | 2026-02-28 | 0.70% | $17.44M |
| Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND | 323,190 | 2025-10-31 | 0.68% | $8.88M |
| Fidelity Hastings Street Trust-Fidelity Fund | 321,100 | 2026-04-30 | 0.67% | $16.80M |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 304,600 | 2026-04-30 | 0.64% | $15.93M |
| Fidelity Securities Fund-Fidelity Series Small Cap Opportunities Fund | 303,100 | 2026-02-28 | 0.64% | $15.86M |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 301,640 | 2026-02-28 | 0.63% | $9.28M |
| Variable Insurance Products Fund II-VIP Contrafund Portfolio | 286,900 | 2026-02-28 | 0.60% | $8.45M |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 276,251 | 2026-01-31 | 0.58% | $8.13M |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 271,501 | 2025-12-31 | 0.57% | $8.09M |
| iShares Trust-iShares Russell 2000 Value ETF | 243,159 | 2026-03-31 | 0.51% | $7.24M |
| HARTFORD MUTUAL FUNDS INC/CT-THE HARTFORD HEALTHCARE FUND | 225,661 | 2025-10-31 | 0.50% | $7.14M |
| iShares Trust-iShares Biotechnology ETF | 195,237 | 2026-01-31 | 0.41% | $5.70M |